Bonum Therapeutics creates a technology platform to treat a wide range of diseases.
Bonum Therapeutics has raised $26.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2026.
Bonum Therapeutics's investors include Vivo Capital, Digitalis Ventures, RiverVest, Codon Capital, 3×5 Partners.
Bonum Therapeutics is headquartered in Seattle, United States.
Bonum Therapeutics creates a technology platform to treat a wide range of diseases.
Bonum Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Bonum Therapeutics — Funding & Investors." VCBacked, April 17, 2026, https://www.vcbacked.co/company/bonum-therapeutics. Accessed July 21, 2026.
VCBacked. (2026). Bonum Therapeutics — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/bonum-therapeutics
{{cite web |title=Bonum Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/bonum-therapeutics |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated